The HDAC inhibitor vorinostat induces the upregulation of GD2 on the surface of MNA-NB cells and has a synergistic effect on the inhibition of MNA-NB by an anti-GD2 mAb (Kroesen et al., 2016). The gene discussed is HDAC9; the disease is neuroblastoma.